跳至主要内容
临床试验/JPRN-jRCT1080221230
JPRN-jRCT1080221230未知4 期

Pharmacokinetics study of Donepezil HCl in subjects receiving haemodialysis.

Eisai Co., Ltd.0 个研究点目标入组 12 人开始时间: 2010年9月3日最近更新:
适应症

试验速览

阶段
4 期
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • end-stage renal disease who were receiving haemodialysis.
  • -Subject who are able and willing to give written informed consent.

排除标准

  • -Subjects with known hypersensitivity to drugs or foods.
  • -Subjects with a corrected QT interval greater than 450msec at screening period.

研究者

相似试验